The results suggest that trait NA does not cause an increase in the reporting of physical symptoms in an illness or intervention that causes highly specific or immediate symptoms. However, trait NA plays an important role in the process of misattributing common symptoms to intervention or illness-related causes and this process may help explain the association between trait NA and symptom reporting.
Older ill travelers are more likely to suffer from certain life-threatening diseases and would benefit from reinforcement of specific preventive measures including use of anti-thrombosis compression stockings and sufficient hydration and exercises during long-distance flights, hand hygiene, use of disposable handkerchiefs, consideration of face-masks in crowded conditions, influenza and pneumococcal vaccines, progressive acclimatization to altitude, consideration of acetazolamide, and use of repellents and mosquito nets. Antibiotics for the presumptive treatment of respiratory and urinary tract infections may be considered, as well as antacid medications. At-risk patients should be referred to a specialist for medical evaluation before departing, and optimal control of co-morbidities such as cardiovascular and chronic obstructive pulmonary diseases should be achieved, particularly for high-altitude travel.
Executive Summary• Technical ideas in software engineering evolve in predictable ways• This evolution pattern sets expectations for software architecture research• Lessons for developers: what to expect of software architecture research, now and in the future• Lessons for researchers: useful research paradigms and validation techniques
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.